EC Number   |
Title |
Organism |
|---|
   3.4.14.9 | A tripeptidyl peptidase 1 is a binding partner of the Golgi pH regulator (GPHR) in Dictyostelium |
Dictyostelium discoideum |
| 3.4.14.9 | Analysis of catalytic properties of tripeptidyl peptidase I (TTP-I), a serine carboxyl lysosomal protease, and its detection in tissue extracts using selective FRET peptide substrate |
Homo sapiens |
| 3.4.14.9 | Analysis of catalytic properties of tripeptidyl peptidase I (TTP-I), a serine carboxyl lysosomal protease, and its detection in tissue extracts using selective FRET peptide substrate |
Rattus norvegicus |
| 3.4.14.9 | Analysis of catalytic properties of tripeptidyl peptidase I (TTP-I), a serine carboxyl lysosomal protease, and its detection in tissue extracts using selective FRET peptide substrate |
Rattus norvegicus Wistar |
| 3.4.14.9 | Effect of acute hypoxic shock on the rat brain morphology and tripeptidyl peptidase I activity |
Rattus norvegicus |
| 3.4.14.9 | Inducible transgenic expression of tripeptidyl peptidase 1 in a mouse model of late-infantile neuronal ceroid lipofuscinosis |
Mus musculus |
| 3.4.14.9 | Inducible transgenic expression of tripeptidyl peptidase 1 in a mouse model of late-infantile neuronal ceroid lipofuscinosis |
Mus musculus C57BL/6 |
| 3.4.14.9 | Lysosomal enzyme tripeptidyl peptidase 1 destabilizes fibrillar Abeta by multiple endoproteolytic cleavages within the beta-sheet domain |
Homo sapiens |
| 3.4.14.9 | Validity of a rapid and simple fluorometric tripeptidyl peptidase 1 (TPP1) assay using dried blood specimens to diagnose CLN2 disease |
Homo sapiens |
| 3.4.14.9 | AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL |
Chlorocebus sabaeus |
